|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Corgentech Inc., of South San Francisco, was issued U.S. Patent No. 6,774,118, which covers a method for preventing formation of neointimal thickening leading to restenosis and vessel occlusion with any double-stranded oligonucleotide decoy that binds to the transcription factor E2F, regardless of the sequence of such decoy.
Curis Inc., of Cambridge, Mass., was issued U.S. Patent No. 6,767,888 titled "Neuroprotective methods and reagents," which claims methods for treatment with Hedgehog pathway-stimulating polypeptides to limit the damage caused to the brain by a stroke or other ischemic condition.
Cyntellect Inc., of San Diego, was awarded U.S. Patent ...